AGIOS PHARMACEUTICALS INC's ticker is and the CUSIP is 00847X954. A total of 4 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,254,825 | +58.8% | 50,700 | +81.7% | 0.00% | – |
| Q2 2023 | $790,128 | +0.6% | 27,900 | -18.4% | 0.00% | – |
| Q1 2023 | $785,574 | -75.8% | 34,200 | -70.4% | 0.00% | -100.0% |
| Q4 2022 | $3,240,432 | -28.7% | 115,400 | -28.2% | 0.00% | -50.0% |
| Q3 2022 | $4,545,000 | +141.2% | 160,700 | +89.1% | 0.00% | +100.0% |
| Q2 2022 | $1,884,000 | – | 85,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 24,100 | $1,044,000 | 0.00% |
| SIMPLEX TRADING, LLC | 333 | $1,442,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 62,100 | $2,691,000 | 0.00% |